Celltrion’s Remsima SC Biosimilar Starts Strong In EU5 Countries

New Study Follows Approval For IBD Indications Last Year

 
• By Dean Rudge
  
IBD
The report sampled 246 EU5 gastroenterologists in November and December last year. • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products